# A Study of Axiron® in Healthy Participants

> **NCT02004132** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 12 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Axiron

## Key facts

- **NCT ID:** NCT02004132
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2014-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02004132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02004132, "A Study of Axiron® in Healthy Participants". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02004132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*